183 related articles for article (PubMed ID: 3877889)
1. A 99Tcm-labelled radiotracer for the investigation of cerebral vascular disease.
Ell PJ; Hocknell JM; Jarritt PH; Cullum I; Lui D; Campos-Costa D; Nowotnik DP; Pickett RD; Canning LR; Neirinckx RD
Nucl Med Commun; 1985 Aug; 6(8):437-41. PubMed ID: 3877889
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of regional cerebral blood flow images by SPECT using xenon-133, iodine-123 IMP, and technetium-99m HM-PAO.
Nakano S; Kinoshita K; Jinnouchi S; Hoshi H; Watanabe K
J Nucl Med; 1989 Feb; 30(2):157-64. PubMed ID: 2786931
[TBL] [Abstract][Full Text] [Related]
3. Cerebral uptake and retention of 99Tcm-hexamethylpropyleneamine oxime (99Tcm-HM-PAO).
Holmes RA; Chaplin SB; Royston KG; Hoffman TJ; Volkert WA; Nowotnik DP; Canning LR; Cumming SA; Harrison RC; Higley B
Nucl Med Commun; 1985 Aug; 6(8):443-7. PubMed ID: 3877890
[TBL] [Abstract][Full Text] [Related]
4. Development of a 99Tcm-labelled radiopharmaceutical for cerebral blood flow imaging.
Nowotnik DP; Canning LR; Cumming SA; Harrison RC; Higley B; Nechvatal G; Pickett RD; Piper IM; Bayne VJ; Forster AM
Nucl Med Commun; 1985 Sep; 6(9):499-506. PubMed ID: 3877892
[TBL] [Abstract][Full Text] [Related]
5. Does the washout phenomenon of Tc-99m HM-PAO correlate to the "filling-in" phenomenon of I-123 IMP with brain SPECT?
Hayashida K; Nishimura T; Imakita S; Uehara T
Neuroradiology; 1990; 32(3):196-9. PubMed ID: 2215903
[TBL] [Abstract][Full Text] [Related]
6. A comparison of Tc-99m HM-PAO and I-123 IMP cerebral SPECT images in Alzheimer's disease and multi-infarct dementia.
Gemmell HG; Sharp PF; Besson JA; Ebmeier KP; Smith FW
Eur J Nucl Med; 1988; 14(9-10):463-6. PubMed ID: 3265101
[TBL] [Abstract][Full Text] [Related]
7. [99mTc-hexamethyl-propyleneamine oxime cerebral perfusion SPECT in patients with cerebrovascular disease].
Jinnouchi S; Hoshi H; Yoshimura H; Nagamachi S; Ohnishi T; Uwada O; Futami S; Watanabe K; Nakano S; Kinoshita K
Kaku Igaku; 1988 Jan; 25(1):31-8. PubMed ID: 3259643
[No Abstract] [Full Text] [Related]
8. Technetium-99m-d, 1-HM-PAO: a new radiopharmaceutical for imaging regional brain perfusion using SPECT--a comparison with iodine-123 HIPDM.
Leonard JP; Nowotnik DP; Neirinckx RD
J Nucl Med; 1986 Dec; 27(12):1819-23. PubMed ID: 3491188
[TBL] [Abstract][Full Text] [Related]
9. Mismatch between iodine-123 IMP and technetium-99m HM-PAO brain perfusion imaging in a patient with meningioma.
Hoshi H; Jinnouchi S; Watanabe K; Nakano S; Kinoshita K
Clin Nucl Med; 1987 Sep; 12(9):737-40. PubMed ID: 3665318
[TBL] [Abstract][Full Text] [Related]
10. SPECT with [99mTc]-d,l-hexamethyl-propylene amine oxime (HM-PAO) compared with regional cerebral blood flow measured by PET: effects of linearization.
Yonekura Y; Nishizawa S; Mukai T; Fujita T; Fukuyama H; Ishikawa M; Kikuchi H; Konishi J; Andersen AR; Lassen NA
J Cereb Blood Flow Metab; 1988 Dec; 8(6):S82-9. PubMed ID: 3263981
[TBL] [Abstract][Full Text] [Related]
11. Dynamic SPECT with technetium-99m HM-PAO in meningiomas--a comparison with iodine-123 IMP.
Nakano S; Kinoshita K; Jinnouchi S; Hoshi H; Watanabe K
J Nucl Med; 1989 Jun; 30(6):1101-5. PubMed ID: 2786949
[TBL] [Abstract][Full Text] [Related]
12. [Intrasubject comparison of regional cerebral blood flow between N-isopropyl-p-[123I]iodoamphetamine SPECT and 99mTc-hexamethylpropyleneamine oxime SPECT in patients with ischemic cerebrovascular disease].
Isaka Y; Yoshikawa T; Ohe Y; Nakayama H; Abe T; Ashida K; Imaizumi M; Tanaka S
Kaku Igaku; 1995 Feb; 32(2):131-8. PubMed ID: 7715098
[TBL] [Abstract][Full Text] [Related]
13. Brain SPECT imaging with 99Tcm-hexamethylpropyleneamine oxime in the early detection of cerebral infarction: comparison with transmission computed tomography.
Yeh SH; Liu RS; Hu HH; Wong WJ; Lo YK; Lai ZY; Huang JC; Chang SL; Wang SJ; Chu FL
Nucl Med Commun; 1986 Dec; 7(12):873-8. PubMed ID: 3494968
[TBL] [Abstract][Full Text] [Related]
14. Tomographic studies of rCBF with 99mTc-HM-PAO SPECT in comparison with PET in patients with primary brain tumors.
Langen KJ; Herzog H; Rota E; Roosen N; Wieler H; Kiwit J; Kuwert T; Storch-Becker A; Feinendegen L
Neurosurg Rev; 1987; 10(1):23-4. PubMed ID: 3499584
[TBL] [Abstract][Full Text] [Related]
15. [Clinical experience of 99mTc-hexamethylpropyleneamine oxime (99mTc-HM-PAO) in imaging of regional cerebral blood flow].
Tsukamoto E; Itoh K; Kamiyama H; Mabuchi S; Furudate M
Kaku Igaku; 1987 Oct; 24(10):1573-9. PubMed ID: 3502012
[No Abstract] [Full Text] [Related]
16. [Usefulness of 99mTc-ECD SPECT in diseases of the central nerve system: special reference to a comparison with 123I-IMP and 99mTc-HM-PAO SPECT].
Ono S; Yanagimoto S; Mimura H; Otsuka N; Nagai K; Morita K; Tomomitsu T; Muranaka A; Watanabe A; Ishii R
Kaku Igaku; 1992 Dec; 29(12):1429-40. PubMed ID: 1491488
[TBL] [Abstract][Full Text] [Related]
17. [Tc-99m-HMPAO brain scintigraphy: a comparative study with I-123-IMP].
Nishimoto H; Yamamoto Y; Yoshida S; Akagi N; Ohara S; Kamiike O; Maeda T
Kaku Igaku; 1989 Apr; 26(4):545-50. PubMed ID: 2788761
[No Abstract] [Full Text] [Related]
18. SPECT with 99Tcm-HMPAO and 99Tcm-pertechnetate to assess regional cerebral blood flow (rCBF) and blood volume (rCBV). Preliminary results in cerebrovascular disease and interictal epilepsy.
Buell U; Stirner H; Braun H; Kreiten K; Ferbert A
Nucl Med Commun; 1987 Jul; 8(7):519-24. PubMed ID: 2825090
[No Abstract] [Full Text] [Related]
19. Dual isotope brain SPECT imaging for monitoring cognitive activation: initial studies in humans.
O'Leary DS; Madsen MT; Hurtig R; Kirchner PT; Rezai K; Rogers M; Andreasen NC
Nucl Med Commun; 1993 May; 14(5):397-404. PubMed ID: 8510881
[TBL] [Abstract][Full Text] [Related]
20. SPECT images of technetium-99m-ethyl cysteinate dimer in cerebrovascular diseases: comparison with other cerebral perfusion tracers and PET.
Tsuchida T; Nishizawa S; Yonekura Y; Sadato N; Iwasaki Y; Fujita T; Matoba N; Magata Y; Tamaki N; Konishi J
J Nucl Med; 1994 Jan; 35(1):27-31. PubMed ID: 8271056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
